Evidence map›Paper›PMID 40756289›Full record

ArticleSisli Etfal Hastanesi tip bulteni2025

A Re-emerging Disease Linked to Complementary Medicine: Argyria.

Ahmet Kayaalti, Asli Aksu Cerman, Ilknur Kivanc Altunay, Birgul Ozkesici Kurt

Abstract read
In one paragraph

Article in Sisli Etfal Hastanesi tip bulteni, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmet KayaaltiDepartment of Dermatology, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Asli Aksu CermanDepartment of Dermatology, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Ilknur Kivanc AltunayDepartment of Dermatology, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Birgul Ozkesici KurtDepartment of Dermatology, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Argyria can be described as the deposition of silver in the skin taken orally or through direct skin inoculation, causing discoloration of the skin and mucosa. In recent years, the increasing trend of people towards complementary medicine and marketing the colloidal form of silver is causing a resurgence of cases of argyria. Therefore, we aim to report a 16-year-old male patient who applied to our outpatient clinic and highlight this increasing trend by presenting a patient case. In the presented case, discoloration of the skin is much more pronounced on sun-exposed areas as in the literature, with the catalytic effect of sunlight on silver. In order to avoid this permanent situation, the authorities should take measures such as restricting the sale of products containing silver or limiting the silver content of products. Raising awareness is strongly recommended.

Indexed as

Argyriacolloidal silversilverskin pigmentation

Identifiers

PMID40756289
PMCPMC12314461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.